Synovial inflammation analyzed by 3-T magnetic resonance imaging in etanercept-treated patients with rheumatoid arthritis indicates persistent disease activity despite of clinical remission: A pilot study

被引:1
作者
Oleszowsky, Mara
Willinek, Winfried [1 ]
Marinova, Milka [2 ]
Seidel, Matthias F. [3 ,4 ]
机构
[1] Dept Radiol Neuroradiol Sonog & Nucl Med, Trier, Germany
[2] Univ Hosp Bonn, Dept Radiol, Bonn, Germany
[3] Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany
[4] Schmerzklin Basel, Basel, Switzerland
关键词
Etanercept; MRI; remission; rheumatoid arthritis; BONE-MARROW EDEMA; JOINT DAMAGE; MRI; TOCILIZUMAB;
D O I
10.1080/14397595.2018.1467525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate joint inflammation using 3-T MRI in rheumatoid arthritis (RA) patients treated with conventional disease modifying anti-rheumatic drugs (cDMARDs) as compared to inhibitors for tumor necrosis factor alpha (TNFi) over 12 months. Methods: Prospective epidemiologic clinical pilot study using the RA MRI system (RAMRIS), the visual analog scale (VAS, 0-100) and the Disease Activity Score 28-joint count (DAS28) at baseline, 4, and 12 months after initiation of etanercept (ETA). Ten patients with inadequate response to two cDMARDs were treated with ETA and compared to 10 patients responding to cDMARDs. Results: In cDMARD patients, parameters at baseline and 12 months did not change: VAS: 21.0 +/- 11.3 and 20.2 +/- 24.6; DAS28: 2.1 +/- 0.6 and 2.9 +/- 1.0; and RAMRIS: 11.0 +/- 2.3 and 11.8 +/- 2.8, respectively. In contrast, in the ETA-patients the same parameters were as follows at baseline, 4, and 12 months: VAS: 46.3 +/- 7.9, 23.9 +/- 7.1, and 24.0 +/- 6.3 (each p = .04); DAS28: 3.8 +/- 0.4, 2.8 +/- 0.3 (ns), and 2.5 +/- 0.3 (p = .01); and RAMRIS: 28.9 +/- 5.0, 25.8 +/- 4.7 (ns), and 24.6 +/- 4.5 (ns). Comparing ETA and cDMARD patients, RAMRIS was significantly different. Conclusion: The data suggest that synovial inflammation and DAS28 remission are separate entities in RA. MRI scoring before starting a treatment may therefore indicate the requirement for TNFi.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 25 条
[1]  
Anderson M W, 1998, Curr Probl Diagn Radiol, V27, P187
[2]   RADIOGRAPHIC CHANGES IN EARLY RHEUMATOID DISEASE [J].
BROOK, A ;
CORBETT, M .
ANNALS OF THE RHEUMATIC DISEASES, 1977, 36 (01) :71-73
[3]   Synovitis and bone inflammation in early rheumatoid arthritis: high-resolution multi-pinhole SPECT versus MRI [J].
Buchbender, Christian ;
Ostendorf, Benedikt ;
Mattes-Gyoergy, Katalin ;
Miese, Falk ;
Wittsack, Hans-Joerg ;
Quentin, Michael ;
Specker, Christof ;
Schneider, Matthias ;
Antoch, Gerald ;
Mueller, Hans-Wilhelm ;
Scherer, Axel .
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2013, 19 (01) :20-24
[4]   The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy [J].
Conaghan, Philip G. ;
Peterfy, Charles ;
Olech, Ewa ;
Kaine, Jeffrey ;
Ridley, David ;
DiCarlo, Julie ;
Friedman, Josh ;
Devenport, Jenny ;
Troum, Orrin .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (05) :810-816
[5]   Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial [J].
Conaghan, Philip G. ;
Emery, Paul ;
Ostergaard, Mikkel ;
Keystone, Edward C. ;
Genovese, Mark C. ;
Hsia, Elizabeth C. ;
Xu, Weichun ;
Rahman, Mahboob U. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (11) :1968-1974
[6]   No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study [J].
Dohn, Uffe Moller ;
Ejbjerg, Bo ;
Boonen, Annelies ;
Hetland, Merete Lund ;
Hansen, Michael Sejer ;
Knudsen, Lene Surland ;
Hansen, Annette ;
Madsen, Ole Rintek ;
Hasselquist, Maria ;
Moller, Jakob M. ;
Ostergaard, Mikkel .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) :252-258
[7]   Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis [J].
Escudero-Vilaplana, Vicente ;
Ramirez-Herraiz, Esther ;
Trovato-Lopez, Nicolas ;
Alanon-Plaza, Estefania ;
Jose Bellini, Maria ;
Herranz-Alonso, Ana ;
Maria Bellon-Cano, Jose ;
Morell-Baladron, Alberto ;
Sanjurjo-Saez, Maria .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2012, 15 (03) :355-360
[8]   MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis [J].
Forslind, K. ;
Svensson, B. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (02) :99-102
[9]   Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression [J].
Haavardsholm, E. A. ;
Boyesen, P. ;
Ostergaard, M. ;
Schildvold, A. ;
Kvien, T. K. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) :794-800
[10]  
Krabbe S, 2016, SCAND J RHEUMATOL, V28, P1